{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:21:59Z","timestamp":1790018519608,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":3427,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.3945\/ajcn.113.060228","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:19Z","timestamp":1377129619000},"page":"1012-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"title":["Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?"],"prefix":"10.1016","volume":"98","author":[{"given":"Carla M","family":"Prado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R","family":"Lieffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Esfandiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Antoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie E","family":"Baracos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3945\/ajcn.113.060228_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.1993.126","article-title":"Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia","volume":"67","author":"Smith","year":"1993","journal-title":"Br J Cancer"},{"key":"10.3945\/ajcn.113.060228_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.arr.2009.02.001","article-title":"Powerful signals for weak muscles","volume":"8","author":"Saini","year":"2009","journal-title":"Ageing Res Rev"},{"key":"10.3945\/ajcn.113.060228_bib3","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.3945\/ajcn.113.060228_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.3945\/ajcn.113.060228_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"key":"10.3945\/ajcn.113.060228_bib6","first-page":"7","article-title":"Overweight and obese patients with solid tumors may have sarcopenia, poor prognosis and early features of cachexia","volume":"8","author":"Prado","year":"2010","journal-title":"Int J Body Compos Res"},{"key":"10.3945\/ajcn.113.060228_bib7","first-page":"439","article-title":"Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis","volume":"13","author":"Peng","year":"2011","journal-title":"HPB(Oxford)"},{"key":"10.3945\/ajcn.113.060228_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clnu.2011.05.008","article-title":"Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food","volume":"30","author":"Deutz","year":"2011","journal-title":"Clin Nutr"},{"key":"10.3945\/ajcn.113.060228_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clnu.2012.05.003","article-title":"Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia","volume":"31","author":"Winter","year":"2012","journal-title":"Clin Nutr"},{"key":"10.3945\/ajcn.113.060228_bib10","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-09-1525","article-title":"Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer","volume":"15","author":"Tan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.3945\/ajcn.113.060228_bib11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.113.060228_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.3945\/ajcn.113.060228_bib13","doi-asserted-by":"crossref","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.113.060228_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.3945\/ajcn.113.060228_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.3945\/ajcn.113.060228_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/SPC.0b013e328331124a","article-title":"The emerging role of computerized tomography in assessing cancer cachexia","volume":"3","author":"Prado","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.3945\/ajcn.113.060228_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.clnu.2011.12.011","article-title":"Body composition: why, when and for who?","volume":"31","author":"Thibault","year":"2012","journal-title":"Clin Nutr"},{"key":"10.3945\/ajcn.113.060228_bib18","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol"},{"key":"10.3945\/ajcn.113.060228_bib19","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.3945\/ajcn.113.060228_bib20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1152\/jappl.1988.64.3.1038","article-title":"Strength conditioning in older men: skeletal muscle hypertrophy and improved function","volume":"64","author":"Frontera","year":"1988","journal-title":"J Appl Physiol"},{"key":"10.3945\/ajcn.113.060228_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2012.144","article-title":"Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma","volume":"106","author":"Prado","year":"2012","journal-title":"Br J Cancer"},{"key":"10.3945\/ajcn.113.060228_bib22","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3945\/ajcn.113.060228_bib23","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","article-title":"Effect of a protein and energy dense N\u20133 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial","volume":"52","author":"Fearon","year":"2003","journal-title":"Gut"},{"key":"10.3945\/ajcn.113.060228_bib24","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/cncr.22944","article-title":"A placebo-controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group","volume":"110","author":"Jatoi","year":"2007","journal-title":"Cancer"},{"key":"10.3945\/ajcn.113.060228_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","article-title":"A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9)","volume":"68","author":"Jatoi","year":"2010","journal-title":"Lung Cancer"},{"key":"10.3945\/ajcn.113.060228_bib26","first-page":"18","article-title":"A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia","volume":"6","author":"Wiedenmann","year":"2008","journal-title":"J Support Oncol"},{"key":"10.3945\/ajcn.113.060228_bib27","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","article-title":"Cancer cachexia: developing multimodal therapy for a multidimensional problem","volume":"44","author":"Fearon","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.3945\/ajcn.113.060228_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.3945\/ajcn.113.060228_bib29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1200\/JCO.2009.24.9730","article-title":"Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study","volume":"28","author":"Antoun","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523052693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523052693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/98\/4\/1012\/23828939\/1012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T08:39:17Z","timestamp":1685176757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523052693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0002916523052693"],"URL":"https:\/\/doi.org\/10.3945\/ajcn.113.060228","relation":{},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/ajcn.113.060228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}